Lyrica
Product Images NDC 16590-503

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Lyrica (NDC 16590-503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image (Lyrica 50 mg)

Label Image (Lyrica 50 mg)
FDA Label Image

Figure Of The Cockcroft And Gault Equation (Lyrica 1)

Figure Of The Cockcroft And Gault Equation (Lyrica 1)
FDA Label Image

Figure 8: Patients Achieving Various Levels Of Pain Relief – Fibromyalgia Study F1 (Lyrica 10)

Figure 8: Patients Achieving Various Levels Of Pain Relief – Fibromyalgia Study F1 (Lyrica 10)
FDA Label Image

Figure 9: Time To Loss Of Therapeutic Response, Fibromyalgia Study F2 (kaplan-meier Analysis) (Lyrica 11)

Figure 9: Time To Loss Of Therapeutic Response, Fibromyalgia Study F2 (kaplan-meier Analysis) (Lyrica 11)
FDA Label Image

The Chemical Structure Of Pregabalin. (Lyrica 2)

The Chemical Structure Of Pregabalin. (Lyrica 2)
FDA Label Image

Figure 1: Patients Achieving Various Levels Of Pain Relief – Study Dpn 1 (Lyrica 3)

Figure 1: Patients Achieving Various Levels Of Pain Relief – Study Dpn 1 (Lyrica 3)
FDA Label Image

Figure 2: Patients Achieving Various Levels Of Pain Relief – Study Dpn 2 (Lyrica 4)

Figure 2: Patients Achieving Various Levels Of Pain Relief – Study Dpn 2 (Lyrica 4)
FDA Label Image

Figure 3: Patients Achieving Various Levels Of Pain Relief – Study Phn 1 (Lyrica 5)

Figure 3: Patients Achieving Various Levels Of Pain Relief – Study Phn 1 (Lyrica 5)
FDA Label Image

Figure 4: Patients Achieving Various Levels Of Pain Relief – Study Phn 2 (Lyrica 6)

Figure 4: Patients Achieving Various Levels Of Pain Relief – Study Phn 2 (Lyrica 6)
FDA Label Image

Figure 5: Patients Achieving Various Levels Of Pain Relief – Study Phn 3 (Lyrica 7)

Figure 5: Patients Achieving Various Levels Of Pain Relief – Study Phn 3 (Lyrica 7)
The text is showing the percent improvement in pain from baseline for two types of medications - Pregatalin and Pregabalin, taken three times a day. The name "Placata" is also mentioned but it is not clear what it refers to.*
FDA Label Image

Figure 6. Responder Rate By Add-on Epilepsy Study (Lyrica 8)

Figure 6. Responder Rate By Add-on Epilepsy Study (Lyrica 8)
FDA Label Image

Figure 7. Seizure Reduction By Dose (all Partial Onset Seizures) For Studies E1, E2, And E3 (Lyrica 9)

Figure 7. Seizure Reduction By Dose (all Partial Onset Seizures) For Studies E1, E2, And E3 (Lyrica 9)
This is not a readable text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.